Hepatic angiogenesis and fibrosis are common features in morbidly obese patients

被引:33
作者
Ciupinska-Kajor, Monika [1 ]
Hartleb, Marek [2 ]
Kajor, Maciej [1 ]
Kukla, Michal [3 ]
Wylezol, Mariusz [4 ]
Lange, Dariusz [5 ]
Liszka, Lukasz [1 ]
机构
[1] Med Univ Silesia, Dept Pathomorphol, PL-40752 Katowice, Poland
[2] Med Univ Silesia, Dept Gastroenterol & Hepatol, PL-40752 Katowice, Poland
[3] Med Univ Silesia, Dept Pathophysiol, Zabrze, Poland
[4] Mil Inst Aviat Med, Dept Surg, Warsaw, Poland
[5] Inst Oncol, Dept Canc Pathol, Gliwice, Poland
关键词
NAFLD; Morbid obesity; Fibrosis; Angiogenesis; NONALCOHOLIC FATTY LIVER; SEVERELY OBESE; HEPATOCYTE APOPTOSIS; METABOLIC SYNDROME; DISEASE; STEATOHEPATITIS; PREDICTORS; BIOPSIES; EXPRESSION; SPECTRUM;
D O I
10.1007/s12072-011-9320-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A mass of visceral adipose tissue is one of the most important determinants of progressive liver injury in nonalcoholic fatty liver disease (NAFLD). In accordance, nonalcoholic steatohepatitis (NASH) and fibrosis are believed to occur more commonly in morbidly obese patients compared with nonobese NAFLD patients. Comparative analysis of NAFLD histopathologic features and angiogenesis activity in morbidly obese and nonobese subjects. Biopsy samples from 40 severely obese (BMI a parts per thousand yen40 kg m(-2)) and 30 nonobese (BMI a parts per thousand currency sign30 kg m(-2)) NAFLD patients were examined. Kleiner's classification was used to diagnose NASH by grading steatosis, cytoplasmatic ballooning of hepatocytes, and lobular inflammation. The severity of fibrosis was evaluated according to the liver fibrosis staging system. Qualitative and quantitative immunohistochemical analyses of VEGF A, Flk-1, and CD34 were performed to study angiogenesis and the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method was used to study hepatocyte apoptosis. Severely obese patients did not differ from nonobese patients with respect to age and sex distribution. NASH was diagnosed in nine (22.5%) severely obese patients and in seven (23.3%) nonobese patients. Fibrosis was more common in morbidly obese patients (82.5 vs. 43.5%, chi(A2) = 11.71, p = 0.003) and was not associated with NASH. Moreover, the severity of fibrosis was greater in obese patients, as advanced fibrosis (bridging fibrosis and cirrhosis) occurred in six (15%) severely obese patients and in two (6.7%) nonobese patients. In morbidly obese individuals, angiogenesis was independent of NASH and was activated at the stage of simple steatosis. In severe obesity, there was a positive relationship between the stage of fibrosis and angiogenic activity. In severely obese patients, fibrosis is probably promoted by mechanisms independent of NASH. In these patients, angiogenesis is activated early in the natural history of NAFLD and correlates with the severity of fibrosis.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 31 条
[1]   Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].
Abrams, GA ;
Kunde, SS ;
Lazenby, AJ ;
Clements, RH .
HEPATOLOGY, 2004, 40 (02) :475-483
[2]   Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells [J].
Aleffi, S ;
Petrai, I ;
Bertolani, C ;
Parola, M ;
Colombatto, S ;
Novo, E ;
Vizzutti, F ;
Anania, FA ;
Milani, S ;
Rombouts, K ;
Laffi, G ;
Pinzani, M ;
Marra, F .
HEPATOLOGY, 2005, 42 (06) :1339-1348
[3]   Non-alcoholic fatty liver syndrome: A hepatic consequence of common metabolic diseases [J].
Angelico, F ;
Del Ben, M ;
Conti, R ;
Francioso, S ;
Feole, K ;
Maccioni, D ;
Antonini, TM ;
Alessandri, C .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (05) :588-594
[4]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[5]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[6]   Obesity and nonalcoholic fatty liver disease [J].
Angulo, Paul .
NUTRITION REVIEWS, 2007, 65 (06) :S57-S63
[7]   Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass [J].
Boza, C ;
Riquelme, A ;
Ibañez, L ;
Duarte, I ;
Norero, E ;
Viviani, P ;
Soza, A ;
Fernandez, JI ;
Raddatz, A ;
Guzman, S ;
Arrese, M .
OBESITY SURGERY, 2005, 15 (08) :1148-1153
[8]   Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese [J].
Dixon, JB ;
Bhathal, PS ;
O'Brien, PE .
GASTROENTEROLOGY, 2001, 121 (01) :91-100
[9]   Natural history of nonalcoholic steatohepatitis:: A longitudinal study of repeat liver biopsies [J].
Fassio, E ;
Alvarez, E ;
Domínguez, N ;
Landeira, G ;
Longo, C .
HEPATOLOGY, 2004, 40 (04) :820-826
[10]   Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis [J].
Feldstein, AE ;
Canbay, A ;
Angulo, P ;
Taniai, M ;
Burgart, LJ ;
Lindor, KD ;
Gores, GJ .
GASTROENTEROLOGY, 2003, 125 (02) :437-443